A Study of MG2512 Injection in Participants With Advanced Solid Tumors

Clinical trial NCT07348653 · RECRUITING

Trial details

NCT number: NCT07348653
Sponsor: Shanghai Mabgen Biopharmaceutical Technology Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2026-03-18
Primary completion: 2026-12-01
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.